Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201)-Reference-Cited by-同舟云学术

Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201)

Published:2015-12 Issue:4 Volume:14 Page:277-280
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Sadahiro Sotaro,Morita Satoshi,Sasaki Kazuaki,Sakamoto Kazuhiro,Ohge Hiroki,Takahashi Takao,Tsuchiya Takashi,Sato Toshihiko,Kondo Ken,Ogata Yutaka,Masuko Hiroyuki,Baba Hideo,Maeda Kiyoshi,Hamada Madoka,Itabashi Michio,Nishimura Genichi,Takahashi Keiichi,Ikeda Masataka,Taguri Masataka,Kodaira Susumu

Funder

Japanese Foundation for Multidisciplinary Treatment of Cancer

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference14 articles.

1. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer;Watanabe;Int J Clin Oncol,2012

2. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials;Sakamoto;J Clin Oncol,2004

3. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer;J Clin Oncol,1999

4. National Comprehensive Cancer Network The NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. version 2. 2011. http://www.nccn.org/professionals/physician_gls/recently_updated.asp. Accessed November 29, 2010.

5. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer;Benson;J Clin Oncol,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201);International Journal of Clinical Oncology;2024-06-04

2. Prognostic factors in patients with high-risk stage II colon cancer after curative resection: a post hoc analysis of the JFMC46-1201 trial;International Journal of Colorectal Disease;2023-10-31

3. A multicenter investigation of risk factors for recurrence in elderly patients with stage II colorectal cancer;Annals of Cancer Research and Therapy;2023-02-14

4. Prognostic Value of Preoperative Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Levels for Adjuvant Chemotherapy in Stage II Colorectal Cancer: A Nationwide Multicenter Retrospective Study;Journal of the Anus, Rectum and Colon;2022-10-27

5. Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201);BMC Cancer;2022-02-15